NO20042693L - Kateterpreparat og anvendelser derav - Google Patents

Kateterpreparat og anvendelser derav

Info

Publication number
NO20042693L
NO20042693L NO20042693A NO20042693A NO20042693L NO 20042693 L NO20042693 L NO 20042693L NO 20042693 A NO20042693 A NO 20042693A NO 20042693 A NO20042693 A NO 20042693A NO 20042693 L NO20042693 L NO 20042693L
Authority
NO
Norway
Prior art keywords
applications
catheter preparation
catheter
preparation
Prior art date
Application number
NO20042693A
Other languages
English (en)
Other versions
NO331700B1 (no
Inventor
Charles P Semba
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO20042693L publication Critical patent/NO20042693L/no
Publication of NO331700B1 publication Critical patent/NO331700B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
NO20042693A 2001-11-26 2004-06-25 Anvendelse av preparat for fremstilling av medikament for fjerning av fibrinbundet blodpropp fra kateter, og multiseksjonsforpakning omfattende preparatet NO331700B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26
PCT/US2002/037878 WO2003045466A2 (en) 2001-11-26 2002-11-25 Catheter composition and uses thereof

Publications (2)

Publication Number Publication Date
NO20042693L true NO20042693L (no) 2004-08-25
NO331700B1 NO331700B1 (no) 2012-02-27

Family

ID=23302492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042693A NO331700B1 (no) 2001-11-26 2004-06-25 Anvendelse av preparat for fremstilling av medikament for fjerning av fibrinbundet blodpropp fra kateter, og multiseksjonsforpakning omfattende preparatet

Country Status (28)

Country Link
US (3) US20030206906A1 (no)
EP (1) EP1455858A4 (no)
JP (1) JP4458240B2 (no)
KR (2) KR20100102745A (no)
CN (1) CN100478027C (no)
AR (1) AR037437A1 (no)
AU (2) AU2002365408B2 (no)
BR (1) BR0215098A (no)
CA (1) CA2467645C (no)
CO (1) CO5580795A2 (no)
EA (1) EA007594B1 (no)
EC (2) ECSDI045123S (no)
HR (1) HRP20040502A2 (no)
HU (1) HUP0600436A3 (no)
IL (2) IL162083A0 (no)
IS (1) IS7275A (no)
ME (1) ME00015B (no)
MX (1) MXPA04004948A (no)
MY (1) MY140404A (no)
NO (1) NO331700B1 (no)
NZ (1) NZ533029A (no)
PL (1) PL371760A1 (no)
RS (1) RS46204A (no)
TW (1) TWI262794B (no)
UA (1) UA81235C2 (no)
UY (1) UY27550A1 (no)
WO (1) WO2003045466A2 (no)
ZA (1) ZA200404024B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL371760A1 (en) * 2001-11-26 2005-06-27 Genentech, Inc. Catheter composition and uses thereof
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
CA2662101C (en) 2006-08-28 2015-07-07 Omnio Healer Ab Candidates against infection
JP5566106B2 (ja) * 2006-08-28 2014-08-06 オムニオ・ヒーラー・アクチボラゲット 歯周病の阻止および治療、歯周創傷の治癒の改善および口腔衛生の促進を目的とする新規薬物
CA2668347C (en) * 2006-11-07 2017-06-20 Genentech, Inc. Tissue plasminogen activator variant uses
WO2008150375A1 (en) 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
CA2698721A1 (en) * 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
WO1991017724A1 (en) * 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5849736A (en) 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
BR9408137A (pt) 1993-11-24 1997-08-12 Du Pont Merck Pharma Composto éster de prodroga método de tratamento composição farmacêutica e método de inibição
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
AU5526098A (en) 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
JP2002538226A (ja) 1999-03-11 2002-11-12 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害剤およびアスピリン、組織プラスミノーゲンアクチベータ（ＴＰＡ）、ＧＰＩＩｂ／ＩＩＩａ拮抗剤、低分子量ヘパリンまたはヘパリンの組合せ使用による血栓症の治療
AR022909A1 (es) 1999-03-11 2002-09-04 Du Pont Pharm Co Sinergia entre heparina de bajo peso molecular e inhibidores de la agregacion plaquetaria, que provee una terapia combinada para la prevencion ytratamiento de diversas afecciones tromboembolicas
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
EP1284780B1 (en) 2000-05-10 2008-05-07 Ash Access Technology, Inc. A catheter lock solution including a photo-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
PL371760A1 (en) 2001-11-26 2005-06-27 Genentech, Inc. Catheter composition and uses thereof
US20070014779A1 (en) 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
EP1442753B1 (en) 2003-02-03 2007-02-21 Polaschegg, Hans-Dietrich, Dr.techn. Composition for the prevention of indwelling device related infection
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
CA2668347C (en) 2006-11-07 2017-06-20 Genentech, Inc. Tissue plasminogen activator variant uses

Also Published As

Publication number Publication date
AU2008203131A1 (en) 2008-08-07
AU2002365408B2 (en) 2008-04-24
IL162083A0 (en) 2005-11-20
NO331700B1 (no) 2012-02-27
BR0215098A (pt) 2004-12-14
MY140404A (en) 2009-12-31
PL371760A1 (en) 2005-06-27
US20060257390A1 (en) 2006-11-16
KR20100102745A (ko) 2010-09-24
NZ533029A (en) 2006-05-26
AR037437A1 (es) 2004-11-10
UY27550A1 (es) 2003-06-30
WO2003045466A3 (en) 2003-10-09
AU2002365408A1 (en) 2003-06-10
US7829082B2 (en) 2010-11-09
ME00015B (me) 2010-06-10
JP2005510302A (ja) 2005-04-21
CN1617738A (zh) 2005-05-18
CA2467645C (en) 2017-01-17
WO2003045466A2 (en) 2003-06-05
US20060246050A1 (en) 2006-11-02
HUP0600436A2 (en) 2006-09-28
TW200303743A (en) 2003-09-16
ZA200404024B (en) 2005-07-27
MXPA04004948A (es) 2004-08-11
ECSP045123A (es) 2004-07-23
EA200400712A1 (ru) 2005-06-30
US20030206906A1 (en) 2003-11-06
IS7275A (is) 2004-05-21
TWI262794B (en) 2006-10-01
UA81235C2 (en) 2007-12-25
KR20040054803A (ko) 2004-06-25
CN100478027C (zh) 2009-04-15
HRP20040502A2 (en) 2004-12-31
IL162083A (en) 2012-12-31
CO5580795A2 (es) 2005-11-30
EP1455858A2 (en) 2004-09-15
HUP0600436A3 (en) 2010-12-28
JP4458240B2 (ja) 2010-04-28
ECSDI045123S (no) 2004-07-23
EP1455858A4 (en) 2006-02-15
RS46204A (en) 2006-10-27
EA007594B1 (ru) 2006-12-29
MEP8008A (xx) 2010-02-10
CA2467645A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1370128T3 (da) Kombineret ballepresse og ballevikler
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DE60225431D1 (de) Dialysekatheter
DE60212600D1 (de) Audiocodierung und decodierung
DE60220315D1 (de) Medizinisches verbindungsstück
NO20030832D0 (no) Kondenserte cykliske forbindelser og medisinsk anvendelse derav
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
DE50208638D1 (de) Katheter
DK1513873T3 (da) Terapeutiske epitoper og anvendelser deraf
DK1562968T3 (da) Anti-il-6-antistoffer, sammensætninger, fremgangsmåder og anvendelser
DK1404809T3 (da) Forbedrede hudsubstitutter og anvendelser deraf
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DK1423376T3 (da) Bicyklisk forbindelse, fremstilling og anvendelse deraf
NO20034159L (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
BR0110168B1 (pt) implante e elemento médico.
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
DE60205718D1 (de) Flexibler wellschlauch und anschlussverfahren
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20042693L (no) Kateterpreparat og anvendelser derav
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
NO20040214L (no) Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
DE50207147D1 (de) Endoskopischer Katheter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees